120 related articles for article (PubMed ID: 38104376)
1. Synthesis of melampomagnolide B derivatives as potential anti-Triple Negative Breast Cancer agents.
Chen T; Chen X; Liu L; Zhang Q; Ding Y
Eur J Med Chem; 2024 Jan; 264():116024. PubMed ID: 38104376
[TBL] [Abstract][Full Text] [Related]
2. Budlein A methylacrylate demonstrates potent activity against triple-negative breast cancer by targeting IκBα kinase and exportin-1.
Wang XZ; Feng Y; Han YF; Bian Y; Liang J; Wen HM; Wu H
Toxicol Appl Pharmacol; 2020 Dec; 408():115263. PubMed ID: 33022283
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and structure-activity relationship studies of parthenolide derivatives as potential anti-triple negative breast cancer agents.
Ge W; Hao X; Han F; Liu Z; Wang T; Wang M; Chen N; Ding Y; Chen Y; Zhang Q
Eur J Med Chem; 2019 Mar; 166():445-469. PubMed ID: 30739826
[TBL] [Abstract][Full Text] [Related]
4. Antitumor properties of novel sesquiterpene lactone analogs as NFκB inhibitors that bind to the IKKβ ubiquitin-like domain (ULD).
Penthala NR; Balasubramaniam M; Dachavaram SS; Morris EJ; Bhat-Nakshatri P; Ponder J; Jordan CT; Nakshatri H; Crooks PA
Eur J Med Chem; 2021 Nov; 224():113675. PubMed ID: 34229108
[TBL] [Abstract][Full Text] [Related]
5. Indole-2-Carboxamide Derivative LG25 Inhibits Triple-Negative Breast Cancer Growth By Suppressing Akt/mTOR/NF-κB Signalling Pathway.
Xu X; Rajamanickam V; Shu S; Liu Z; Yan T; He J; Liu Z; Guo G; Liang G; Wang Y
Drug Des Devel Ther; 2019; 13():3539-3550. PubMed ID: 31631978
[TBL] [Abstract][Full Text] [Related]
6. MMB triazole analogs are potent NF-κB inhibitors and anti-cancer agents against both hematological and solid tumor cells.
Janganati V; Ponder J; Balasubramaniam M; Bhat-Nakshatri P; Bar EE; Nakshatri H; Jordan CT; Crooks PA
Eur J Med Chem; 2018 Sep; 157():562-581. PubMed ID: 30121494
[TBL] [Abstract][Full Text] [Related]
7. Anti-cancer effect of a phytochemical compound - 7R-acetylmelodorinol - against triple-negative breast cancer cells.
Thepmalee C; Sawasdee N; Jenkham P; Thephinlap C; Khoothiam K; Suwannasom N; Chokchaisiri R; Panya A; Yenchitsomanus PT
Biomed Pharmacother; 2023 Oct; 166():115286. PubMed ID: 37573655
[TBL] [Abstract][Full Text] [Related]
8. ROR activation by Nobiletin enhances antitumor efficacy via suppression of IκB/NF-κB signaling in triple-negative breast cancer.
Kim E; Kim YJ; Ji Z; Kang JM; Wirianto M; Paudel KR; Smith JA; Ono K; Kim JA; Eckel-Mahan K; Zhou X; Lee HK; Yoo JY; Yoo SH; Chen Z
Cell Death Dis; 2022 Apr; 13(4):374. PubMed ID: 35440077
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and structure-activity relationship study of a potent MHO7 analogue as potential anti-triple negative breast cancer agent.
Liang JJ; Yu WL; Yang L; Qin KM; Yin YP; Li D; Ni YH; Yan JJ; Zhong YX; Deng ZX; Hong K
Eur J Med Chem; 2022 Jun; 236():114313. PubMed ID: 35390712
[TBL] [Abstract][Full Text] [Related]
10. Identification of a small molecule as inducer of ferroptosis and apoptosis through ubiquitination of GPX4 in triple negative breast cancer cells.
Ding Y; Chen X; Liu C; Ge W; Wang Q; Hao X; Wang M; Chen Y; Zhang Q
J Hematol Oncol; 2021 Jan; 14(1):19. PubMed ID: 33472669
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and validation of novel nitrogen-based chalcone analogs against triple negative breast cancer.
Elkhalifa D; Siddique AB; Qusa M; Cyprian FS; El Sayed K; Alali F; Al Moustafa AE; Khalil A
Eur J Med Chem; 2020 Feb; 187():111954. PubMed ID: 31838326
[TBL] [Abstract][Full Text] [Related]
12. Activation of GPER suppresses migration and angiogenesis of triple negative breast cancer via inhibition of NF-κB/IL-6 signals.
Liang S; Chen Z; Jiang G; Zhou Y; Liu Q; Su Q; Wei W; Du J; Wang H
Cancer Lett; 2017 Feb; 386():12-23. PubMed ID: 27836733
[TBL] [Abstract][Full Text] [Related]
13. Rubioncolin C, a natural naphthohydroquinone dimer isolated from Rubia yunnanensis, inhibits the proliferation and metastasis by inducing ROS-mediated apoptotic and autophagic cell death in triple-negative breast cancer cells.
Li L; Wang J; Feng L; Fan J; Wang J; Tan N; Wang Z
J Ethnopharmacol; 2021 Sep; 277():114184. PubMed ID: 33961996
[TBL] [Abstract][Full Text] [Related]
14. Ginsenoside Rg3 promotes cytotoxicity of Paclitaxel through inhibiting NF-κB signaling and regulating Bax/Bcl-2 expression on triple-negative breast cancer.
Yuan Z; Jiang H; Zhu X; Liu X; Li J
Biomed Pharmacother; 2017 May; 89():227-232. PubMed ID: 28231544
[TBL] [Abstract][Full Text] [Related]
15. Phenanthroindolizidine Alkaloids Isolated from
Reimche I; Yu H; Ariantari NP; Liu Z; Merkens K; Rotfuß S; Peter K; Jungwirth U; Bauer N; Kiefer F; Neudörfl JM; Schmalz HG; Proksch P; Teusch N
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142230
[TBL] [Abstract][Full Text] [Related]
16. Eucannabinolide, a novel sesquiterpene lactone, suppresses the growth, metastasis and BCSCS-like traits of TNBC via inactivation of STAT3.
Zhu Z; Yuan J; Xu X; Wei Y; Yang B; Zhao H
Neoplasia; 2021 Jan; 23(1):36-48. PubMed ID: 33217668
[TBL] [Abstract][Full Text] [Related]
17. Eugenol modulates the NOD1-NF-κB signaling pathway
Shi X; Zhang W; Bao X; Liu X; Yang M; Yin C
Front Endocrinol (Lausanne); 2023; 14():1136067. PubMed ID: 36923216
[TBL] [Abstract][Full Text] [Related]
18. Elevated IL-1β expression induces invasiveness of triple negative breast cancer cells and is suppressed by zerumbone.
Jeon M; Han J; Nam SJ; Lee JE; Kim S
Chem Biol Interact; 2016 Oct; 258():126-33. PubMed ID: 27567548
[TBL] [Abstract][Full Text] [Related]
19. Novel sesquiterpene lactone analogues as potent anti-breast cancer agents.
Nakagawa-Goto K; Chen JY; Cheng YT; Lee WL; Takeya M; Saito Y; Lee KH; Shyur LF
Mol Oncol; 2016 Jun; 10(6):921-37. PubMed ID: 27055598
[TBL] [Abstract][Full Text] [Related]
20. Panepoxydone targets NF-kB and FOXM1 to inhibit proliferation, induce apoptosis and reverse epithelial to mesenchymal transition in breast cancer.
Arora R; Yates C; Gary BD; McClellan S; Tan M; Xi Y; Reed E; Piazza GA; Owen LB; Dean-Colomb W
PLoS One; 2014; 9(6):e98370. PubMed ID: 24896091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
